<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01724nam a22001577a 4500</leader>
  <datafield tag="082" ind1=" " ind2=" ">
    <subfield code="a">610</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Riaz, Aqsa </subfield>
    <subfield code="9">121483</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Complex Materialsfor Skin Diseases /</subfield>
    <subfield code="c">Aqsa Riaz</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2=" ">
    <subfield code="a">Islamabad : </subfield>
    <subfield code="b">SMME- NUST; </subfield>
    <subfield code="c">2025.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">65p.</subfield>
    <subfield code="b">Soft Copy</subfield>
    <subfield code="c">30cm</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">For the development of complex multifunctional materials as advanced wound dressings for the
treatment of skin diseases, particularly chronic and infected wounds. By integrating cerium oxide
nanoparticles and thymol-based deep eutectic solvent hydrogels into a chitosan-gelatin matrix, the
study addresses pressing challenges in wound care, including antimicrobial resistance, limited drug
stability, and poor localization at wound sites. Engineered hydrogels provide sustained release of
active compounds, effectively disrupt biofilms from resistant bacteria such as Staphylococcus
aureus and Escherichia coli, and deliver combined antimicrobial, antioxidant, and antiinflammatory effects. Laboratory evaluations demonstrated significant antibacterial activity,
enhanced biofilm inhibition, and improved healing potential compared to conventional therapies.
The results establish these materials as strong candidates for next generation wound dressings,
with future research focused on optimizing formulation stability and validating in vivo safety. This
work contributes to advancements in wound management by offering promising solutions for
minimizing antimicrobial resistance and enhancing healing outcomes in chronic skin infections.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">MS Biomedical Sciences (BMS)</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Supervisor : Dr. Nosheen Fatima Rana</subfield>
  </datafield>
  <datafield tag="856" ind1=" " ind2=" ">
    <subfield code="u">http://10.250.8.41:8080/xmlui/handle/123456789/55614</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">THE</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">615166</subfield>
    <subfield code="d">615166</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">SMME</subfield>
    <subfield code="b">SMME</subfield>
    <subfield code="c">EB</subfield>
    <subfield code="d">2025-10-14</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">610</subfield>
    <subfield code="p">SMME-TH-1188</subfield>
    <subfield code="r">2025-10-14</subfield>
    <subfield code="w">2025-10-14</subfield>
    <subfield code="y">THE</subfield>
  </datafield>
</record>
